SA-based Apple reseller Digicape has entered into a deal with UK-based start-up xRapid to offer a mobile health solution that provides automatic diagnosis of malaria via an iPhone app.
Using digital imaging technology and artificial intelligence, xRapid says it has developed a platform that can diagnose diseases such as malaria and tuberculosis faster, cheaper and more accurately than conventional methods.
The xRapid solution includes an iPhone, the xRapid mobile app and an attachment system that works on both compound and field microscopes. The test equipment and technology can cope with harsh climates and hot temperatures, making it suitable for healthcare professionals and aid workers in remote areas with limited resources.
The app uses digital imaging technology with an algorithm to diagnose the disease from a magnified image of a blood slide shown through the microscope. Once the test is concluded, the diagnostic report is immediately available for patient education and care to begin and to share with global organisations involved in disease management.
"The app works as a diagnostic system that includes a microscope and requires blood samples and medical handling. It's not a consumer app - it's specifically for the medical or healthcare workers to enable immediate and accurate diagnosis," says Robin Olivier, MD of Digicape.
He notes the app is available free from the Apple App store and its use is dependent on having the right equipment, including the iPhone and a microscope.
According to xRapid, testing is critically important in managing any disease such as malaria as it links the treatment with drug management, vaccine research, resource allocation and patient care on a global scale.
Jean Viry-Babel, xRapid CEO, says xRapid works as a pay-as-you-test service. "Once the user has purchased the hardware device with the xRapid iPhone app, he is able to top up his account with the amount of diagnostic tests he plans to use."
He points out xRapid can be used with any kind of portable or lab microscope to reach all patients anywhere in the world.
"The aim of xRapid is to build a diagnostic platform allowing health workers to diagnose multiple diseases accurately, fast and more easily. Besides malaria, we're also working on a solution for tuberculosis, gonorrhoea and blood cancers.
"We are very excited to be the first iPhone app to diagnose a major disease like malaria. Half of the global population is at risk, and we are very proud to be doing our part in improving the lives of those affected. The m-health revolution is starting to help people all over the world and we are thrilled to be part of it," concludes Viry-Babel.
Share